BACKGROUND
Myeloid differentiation factor 88 (MyD88) is an adaptor molecule critical for
host innate immunity. Studies have shown that signaling via MyD88
contributes to cytokine storm, cardiac dysfunction, and high mortality during endotoxin
shock. However, the specific contribution of MyD88 signaling of immune and cardiac
origins to endotoxin shock remains unknown.
METHODS
Tissue-specific MyD88 deletion models
Cre recombinase transgenic mice with α-myosin heavy chain
(α-MHC) or lysozyme M promoters were cross-bred with MyD88-loxP
(MyD88fl/fl) mice, respectively, to generate cardiomyocyte-
(α-MHC-MyD88−/−) or myeloid-specific
(Lyz-MyD88−/−) MyD88 deletion models and their respective
MyD88fl/fl littermates.
Endotoxin shock model
Mice were subjected to 15 mg/kg lipopolysaccharide (intra-peritoneal
injection). Cardiac function was measured by echocardiography and cytokines by multiplex
assay and quantitative reverse transcription-polymerase chain reaction (qRT-PCR).
RESULTS
α-MHC-MyD88−/− mice had 61% and
87% reduction in MyD88 gene and protein expression in cardiomyocytes,
respectively, whereas Lyz-MyD88−/− had 73% and
67% decrease, respectively, in macrophages (n=3/group). Following
lipopolysaccharide treatment, the two groups of MyD88fl/fl littermates had
46% (n=10) and 60% (n=15) of mortality, respectively.
Both α-MHC- MyD88−/− and
Lyz-MyD88−/− mice had markedly improved survival. Compared
to the MyD88fl/fl littermates, Lyz-MyD88−/− mice
had warmer body temperature, attenuated systemic and cardiac inflammatory cytokine
production, and significantly improved cardiac function, whereas
α-MHC-MyD88−/− mice had decreased myocardial
inducible nitric oxide synthase (iNOS) induction and modestly preserved cardiac
function.
CONCLUSIONS
Both cardiomyocyte- and myeloid-MyD88 signaling play a role in cardiac
dysfunction and mortality during endotoxin shock. Myeloid MyD88 signaling plays a
predominant role in systemic and cardiac inflammation following endotoxin challenge.